RxDoctor Payments Data

Arjun Saini, MD

Dermatology · Fort Smith, ARNPI 1740741024

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 32.4% of the total. That places this record below the midpoint for dermatology clinicians in AR, where the typical reported total is $3,769.

$1,825in general payments, 2019–2025

Across 62 payments — averaging $29.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$592
  • Arcutis Biotherapeutics, Inc.$183
  • Sanofi$158
  • Dermavant Sciences, Inc.$155
  • Johnson & Johnson$138
  • Novartis$122
  • plus $478 from 10 others

What the payments were for

  • Food & beverage$1,74596%
  • Education$804%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,825 in reported general payments places this provider in the 35th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$179,400
Medicare patients
360
Services billed
1,210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Halobetasol Propionate17$1,724
Clobetasol Propionate13$1,616
Permethrin35$1,405
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox11$1,171
Tacrolimus13$1,146
Ketoconazole45$934
Triamcinolone Acetonide61$674
Fluocinonide22$625
Doxycycline Hyclate37$433
Hydrocortisone27$271
Mupirocin26$175
Mometasone Furoate15$74

Paid to pharmacies, not to this prescriber.

Other dermatology in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →